Advertisement
Trulieve Cannabis Corp.

Trulieve Cannabis Corp. Fundamental Analysis

TRLVNYSE
HealthcareMedical - Pharmaceuticals
$8.99
$0.47(5.52%)
U.S. Market opens in 54h 50m
Advertisement

Trulieve Cannabis Corp. Fundamental Analysis

Trulieve Cannabis Corp. (TRLV) shows weak financial fundamentals with a PE ratio of -21.31, profit margin of -6.93%, and ROE of -6.82%. The company generates $1.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position20.52%
PEG Ratio0.22
Current Ratio5.26

Areas of Concern

ROE-6.82%
We analyze TRLV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 17.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
17.9/100

We analyze TRLV's fundamental strength across five key dimensions:

Efficiency Score

Weak

TRLV struggles to generate sufficient returns from assets.

ROA > 10%
-2.92%

Valuation Score

Excellent

TRLV trades at attractive valuation levels.

PE < 25
-21.31
PEG Ratio < 2
0.22

Growth Score

Moderate

TRLV shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TRLV maintains a strong and stable balance sheet.

Debt/Equity < 1
0.54
Current Ratio > 1
5.26

Profitability Score

Weak

TRLV struggles to sustain strong margins.

ROE > 15%
-681.86%
Net Margin ≥ 15%
-6.93%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TRLV Expensive or Cheap?

P/E Ratio

TRLV trades at -21.31 times earnings. This suggests potential undervaluation.

-21.31

PEG Ratio

When adjusting for growth, TRLV's PEG of 0.22 indicates potential undervaluation.

0.22

Price to Book

The market values Trulieve Cannabis Corp. at 1.48 times its book value. This may indicate undervaluation.

1.48

EV/EBITDA

Enterprise value stands at 3.76 times EBITDA. This is generally considered low.

3.76

How Well Does TRLV Make Money?

Net Profit Margin

For every $100 in sales, Trulieve Cannabis Corp. keeps $-6.93 as profit after all expenses.

-6.93%

Operating Margin

Core operations generate 12.70 in profit for every $100 in revenue, before interest and taxes.

12.70%

ROE

Management delivers $-6.82 in profit for every $100 of shareholder equity.

-6.82%

ROA

Trulieve Cannabis Corp. generates $-2.92 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.92%

Following the Money - Real Cash Generation

Operating Cash Flow

Trulieve Cannabis Corp. produces operating cash flow of $244.78M, showing steady but balanced cash generation.

$244.78M

Free Cash Flow

Trulieve Cannabis Corp. generates strong free cash flow of $197.83M, providing ample flexibility for dividends, buybacks, or growth.

$197.83M

FCF Per Share

Each share generates $1.16 in free cash annually.

$1.16

FCF Yield

TRLV converts 14.67% of its market value into free cash.

14.67%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-21.31

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.22

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.48

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.30

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.54

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.26

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.07

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How TRLV Stacks Against Its Sector Peers

MetricTRLV ValueSector AveragePerformance
P/E Ratio-21.3129.63 Better (Cheaper)
ROE-6.82%223.00% Weak
Net Margin-6.93%-38669.00% (disorted) Weak
Debt/Equity0.540.82 Strong (Low Leverage)
Current Ratio5.264.30 Strong Liquidity
ROA-2.92%-379.00% (disorted) Weak

TRLV outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Trulieve Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ